Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FHLC vs HGHAX overlap: 72% of top holdings shared

Bottom line

How much do FHLC and HGHAX overlap?

72% of their top holdings overlap by weight. 19 securities appear in both funds' top 25, making up 63.1% of FHLC's assets and 63.0% of HGHAX's. They are largely the same portfolio — owning both adds little diversification.

FHLC holds far more positions (337 vs 80), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FHLCHGHAX
Weight overlap (top 25)72%
Shared holdings19
Weight in shared holdings63.1%63.0%
Total positions33780
Expense ratio0.084%1.33%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings FHLC and HGHAX have in common

Holding% of FHLC% of HGHAXOverlap
Eli Lilly & Co13.35%12.03%12.03%
Johnson & Johnson8.93%6.75%6.75%
AbbVie Inc6.42%4.21%4.21%
UnitedHealth Group Inc5.44%4.74%4.74%
Merck & Co Inc4.66%6.00%4.66%
Thermo Fisher Scientific Inc3.09%1.58%1.58%
Amgen Inc3.00%1.39%1.39%
Abbott Laboratories2.66%1.82%1.82%
CVS Health Corp1.92%2.84%1.92%
Intuitive Surgical Inc1.82%2.88%1.82%
Danaher Corp1.80%2.57%1.80%
Vertex Pharmaceuticals Inc1.76%2.64%1.76%
Stryker Corp1.62%1.24%1.24%
Medtronic PLC1.59%1.12%1.12%
Elevance Health Inc1.19%3.00%1.19%
Regeneron Pharmaceuticals Inc1.15%2.02%1.15%
Boston Scientific Corp1.00%1.88%1.00%
HCA Healthcare Inc0.91%1.88%0.91%
Cencora Inc0.83%2.46%0.83%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FHLC

  1. Gilead Sciences Inc — 2.34%
  2. Pfizer Inc — 2.06%
  3. Bristol-Myers Squibb Co — 1.93%
  4. McKesson Corp — 1.52%
  5. Cigna Group/The — 1.06%
  6. Cardinal Health Inc — 0.78%

Only in HGHAX

  1. Edwards Lifesciences Corp — 2.48%
  2. Agilent Technologies Inc — 1.54%
  3. Biogen Inc — 1.36%
  4. Gsk Plc — 1.17%
  5. Centene Corp — 1.10%
  6. Dexcom Inc — 1.01%

Asset mix

Asset typeFHLCHGHAX
Stocks99.7%98.1%
Cash & short-term funds0.2%0.9%
Repurchase agreements—0.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryFHLCHGHAX
US96.5%89.6%
GB0.5%2.4%
IE2.2%2.2%
NL0.1%1.5%
BE—0.8%
DK—0.8%
CH0.1%0.7%
CN—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do FHLC and HGHAX overlap?
About 72% by weight. 19 securities appear in both funds' top 25 holdings; they make up 63.1% of FHLC's assets and 63.0% of HGHAX's. They are largely the same portfolio — owning both adds little diversification.
What stocks do FHLC and HGHAX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.
Should I own both FHLC and HGHAX?
Owning both adds little diversification: most of their top holdings are the same, so most investors pick one — often the one with the lower expense ratio.
Which holds more stocks, FHLC or HGHAX?
FHLC is broader, with 337 positions versus 80 for HGHAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.